Abstract
Sexual dysfunction in men can be manifold. Purely mechanical disorders of seminal deposition due to anatomy are to be differentiated from functional libido and orgasmic disorders, from ejaculation problems or the inability to achieve or maintain erections. While pure orgasmic disturbances are almost in all cases due to psychological or psychiatric causes, libido and erectile dysfunction may also have hormonal causes and thus be symptoms of androgen deficiency. Additional clinical symptoms of hypogonadism or objectifiable findings such as testicular atrophy, changes in secondary sexual characteristics, or ejaculate volume allow the organic genesis to be identified in pronounced cases, while in other cases the corresponding indications must be actively sought. Thus, while functional orgasmic and libido disorders are the domain of psychological psychiatric or endocrinological therapeutic approaches, this chapter deals primarily with disorders of seminal deposition and functionally or organically caused disorders of cohabitation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ (2011) Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci 4:158–170. https://doi.org/10.2174/1874609811104020158
Al-Thakafi S, Al-Hathal N (2016) Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol 5:280–289. https://doi.org/10.21037/tau.2016.04.05
Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel AW, Adaikan PG, Becher E, Dean J, Giuliano F, Hellstrom WJ, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO (2014) An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med 11:1392–1422. https://doi.org/10.1111/jsm.12504
Anele UA, Morrison BF, Burnett A (2015) Molecular pathophysiology of priapism: emerging targets. Curr Drug Targets 16:474–483. https://doi.org/10.2174/1389450115666141111111842
Aschenbach R, Steiner T, Kerl MJ, Zangos S, Basche S, Vogl TJ (2013) Endovascular embolisation therapy in men with erectile impotence due to veno-occlusive dysfunction. Eur J Radiol 82:504–507. https://doi.org/10.1016/j.ejrad.2012.10.030
AWMF-Leitlinie (2017). https://www.awmf.org/leitlinien/detail/ll/006-052.html
Bates JN, Kohn TP, Pastuszak AW (2020) Effect of thyroid hormone derangements on sexual function in men and women. Sex Med Rev 8:217–230. https://doi.org/10.1016/j.sxmr.2018.09.005
Bechara A, Casabe A, Rodriguez Baigorri G, Cobreros C (2014) Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study. J Sex Med 11:498–505. https://doi.org/10.1111/jsm.12386
Bjekic MD, Vlajinac HD, Sipetic SB, Marinkovic JM (2006) Risk factors for Peyronie’s disease: a case-control study. BJU Int 97:570–574. https://doi.org/10.1111/j.1464-410X.2006.05969.x
Bodie J, Lewis J, Schow D, Monga M (2003) Laboratory evaluations of erectile dysfunction: an evidence-based approach. J Urol 169:2262–2264. https://doi.org/10.1097/01.ju.0000063940.19080.58
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U (2000) Epidemiology of erectile dysfunction: results of the ‘cologne male survey’. Int J Impot Res 12:305–311. https://doi.org/10.1038/sj.ijir.3900622
Briken P, Matthiesen S, Pietras L, Wiessner C, Klein V, Reed GM, Dekker A (2020) Estimating the prevalence of sexual dysfunction using the new ICD-11 guidelines. Dtsch Arztebl Int 117:653–658. https://doi.org/10.3238/arztebl.2020.0653
Burnett AL (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 16(Suppl 1):S15–S19. https://doi.org/10.1038/sj.ijir.3901209
Burnett AL, Sharlip ID (2013) Standard operating procedures for priapism. J Sex Med 10:180–194. https://doi.org/10.1111/j.1743-6109.2012.02707.x
Burns PR, Rosen RC, Dunn M, Baygani SK, Perelman MA (2015) Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily. J Sex Med 12:720–727. https://doi.org/10.1111/jsm.12818
Cai T, Palumbo F, Liguori G, Mondaini N, Scroppo FI, Di Trapani D, Cocci A, Zucchi A, Verze P, Salonia A, Palmieri A (2019) The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient’s satisfaction: results from a randomized, two-administration route, cross-over clinical trial. Int J Impot Res 31:119–125. https://doi.org/10.1038/s41443-018-0087-6
Carvalheira AA, Pereira NM, Maroco J, Forjaz V (2012) Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med 9:2361–2369. https://doi.org/10.1111/j.1743-6109.2012.02787.x
Cephlapharm (2015) POTABA—Glenwood. https://www.cheplapharm.com/fileadmin/Ablage/Gebrauchsinformationen/palde-001-potaba-kapseln-2015-09-14.pdf
Chen L, Staubli SE, Schneider MP, Kessels AG, Ivic S, Bachmann LM, Kessler TM (2015) Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol 68:674–680. https://doi.org/10.1016/j.eururo.2015.03.031
Chierigo F, Capogrosso P, Dehò F, Pozzi E, Schifano N, Belladelli F, Montorsi F, Salonia A (2019) Long-term follow-up after penile prosthesis implantation—survival and quality of life outcomes. J Sex Med 16:1827–1833. https://doi.org/10.1016/j.jsxm.2019.08.001
Chung E, Wang J (2017) A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction. Expert Rev Med Devices 14:929–934. https://doi.org/10.1080/17434440.2017.1403897
Chung E, Deyoung L, Brock GB (2011) The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med 8:1472–1477. https://doi.org/10.1111/j.1743-6109.2011.02217.x
Ciocanel O, Power K, Eriksen A (2019) Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews. Sex Med 7:251–269. https://doi.org/10.1016/j.esxm.2019.06.001
Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M (2017) Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores. Eur Urol 72:1000–1011. https://doi.org/10.1016/j.eururo.2017.03.032
Cui H, Liu B, Song Z, Fang J, Deng Y, Zhang S, Wang H, Wang Z (2015) Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia 47:20–24. https://doi.org/10.1111/and.12216
Deveci S, Hopps CV, O’Brien K, Parker M, Guhring P, Mulhall JP (2007) Defining the clinical characteristics of Peyronie’s disease in young men. J Sex Med 4:485–490. https://doi.org/10.1111/j.1743-6109.2006.00344.x
Di Maida F, Cito G, Lambertini L, Valastro F, Morelli G, Mari A, Carini M, Minervini A, Cocci A (2021) The natural history of peyronie’s disease. World J Mens Health 39(3):399–405. https://doi.org/10.5534/wjmh.200065. Epub 2020 Jul 8. PMID: 32648381; PMCID: PMC8255406
Dohle GR, Arver S, Bettocchi C, Jones TH, Kliesch S (2020) EAU-Leitlinie Männlicher Hypogonadismus. J Reproduktionsmedizin Endokrinologie 17:66–85
Dong L, Chang D, Zhang X, Li J, Yang F, Tan K, Yang Y, Yong S, Yu X (2019) Effect of low-intensity extracorporeal shock wave on the treatment of erectile dysfunction: a systematic review and meta-analysis. Am J Mens Health 13:1557988319846749. https://doi.org/10.1177/1557988319846749
van Driel MF (2014) Sleep-related erections throughout the ages. J Sex Med 11:1867–1875. https://doi.org/10.1111/jsm.12557
El-Nashaar A, Shamloul R (2007) Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. J Sex Med 4:491–496. https://doi.org/10.1111/j.1743-6109.2006.00243.x
El-Sakka AI (2018) Dehydroepiandrosterone and erectile function: a review. World J Mens Health 36:183–191. https://doi.org/10.5534/wjmh.180005
Farrell MR, Corder CJ, Levine LA (2013) Peyronie’s disease among men who have sex with men: characteristics, treatment, and psychosocial factors. J Sex Med 10:2077–2083. https://doi.org/10.1111/jsm.12202
Feldmann HA, Goldstein I, Hatzichriston DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: Results of the massachusetts male aging study. J Urol 151:54–61
Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF (2006) Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie’s disease. BJU Int 97:625–633. https://doi.org/10.1111/j.1464-410X.2006.05955.x
Fode M, Hatzichristodoulou G, Serefoglu EC, Verze P, Albersen M (2017) Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? Nat Rev Urol 14:593–606. https://doi.org/10.1038/nrurol.2017.119
Fojecki GL, Tiessen S, Osther PJ (2017) Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain. World J Urol 35:1–9. https://doi.org/10.1007/s00345-016-1834-2
Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, Jones N, Kaufman GJ, Carson CC 3rd. (2013) Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo-controlled phase 3 studies. J Urol 190:199–207. https://doi.org/10.1016/j.juro.2013.01.087
Giuliano F, Rowland DL (2013) Standard operating procedures for neurophysiologic assessment of male sexual dysfunction. J Sex Med 10:1205–1211. https://doi.org/10.1111/jsm.12164
Greenstein A, Plymate SR, Katz PG (1995) Visually stimulated erection in castrated men. J Urol 153(3 Pt 1):650–652. https://doi.org/10.1097/00005392-199503000-00027
Habous M, Tal R, Tealab A, Soliman T, Nassar M, Mekawi Z, Mahmoud S, Abdelwahab O, Elkhouly M, Kamr H, Remeah A, Binsaleh S, Ralph D, Mulhall J (2018) Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection. BJU Int 121:293–300. https://doi.org/10.1111/bju.14076
Halls JE, Patel DV, Walkden M, Patel U (2012) Priapism: pathophysiology and the role of the radiologist. Br J Radiol 85 Spec Iss 1:S79–S85. https://doi.org/10.1259/bjr/62360925
Hatzichristodoulou G, Osmonov D, Kübler H, Hellstrom WJG, Yafi FA (2017) Contemporary review of grafting techniques for the surgical treatment of peyronie’s disease. Sex Med Rev 5:544–552. https://doi.org/10.1016/j.sxmr.2017.01.006
Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P, Parnham A, Serefoglu EC (2018) EAU Guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. European Association of Urology. https://uroweb.org/guideline/male-sexual-dysfunction/
Hauch M, Lange C, Cassel-Bähr S (2007) Paartherapie bei sexuellen Störungen am Beispiel des Hamburger Modells. In: Sigusch V (ed) Sexuelle Störungen und ihre Behandlung. Thieme, Stuttgart, pp 155–176
Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W (2004) Extracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trials. J Urol 171(2 Pt 1):740–745. https://doi.org/10.1097/01.ju.0000108060.30363.8d
Hauri D (1984) Therapiemöglichkeiten bei der vaskulär bedingten erektilen Impotenz. Aktuelle Urol 15:350–354
Hebert K, Kohler TS (2019) Acute post-inflatable penile prosthesis glans ischemia: review of incidence, pathophysiology, and management recommendations. J Sex Med 16:1–4. https://doi.org/10.1016/j.jsxm.2018.10.017
Hellstrom WJ (2007) Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors. Int J Clin Pract 61:1547–1554. https://doi.org/10.1111/j.1742-1241.2007.01482.x
Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J (2013) Bother and distress associated with Peyronie’s disease: validation of the Peyronie’s disease questionnaire. J Urol 190(2):627–634. https://doi.org/10.1016/j.juro.2013.01.090. Epub 2013 Jan 31. PMID: 23376705
Hsu B, Cumming RG, Blyth FM, Naganathan V, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ (2015) The longitudinal relationship of sexual function and androgen status in older men: the Concord health and ageing in men project. J Clin Endocrinol Metab 100:1350–1358. https://doi.org/10.1210/jc.2014-4104
Huang ST, Jiann BP (2013) Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction. Int J Impot Res 25:178–182. https://doi.org/10.1038/ijir.2013.8
Husain J, Lynn NN, Jones DK, Collins GN, O’Reilly PH (2000) Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience. BJU Int 86:466–468. https://doi.org/10.1046/j.1464-410x.2000.00827.x
Hussein AA, Alwaal A, Lue TF (2015) All about Peyronie’s disease. Asian J Urol 2:70–78. https://doi.org/10.1016/j.ajur.2015.04.019
Jannini EA, McCabe MP, Salonia A, Montorsi F, Sachs BD (2010) Organic vs. psychogenic? The Manichean diagnosis in sexual medicine. J Sex Med 7:1726–1733. https://doi.org/10.1111/j.1743-6109.2010.01824.x
Jardin A (2000) Erectile Dysfunction. Health Publication Ltd, Plymouth UK, S 711–726
Jefferys A, Siassakos D, Wardle P (2012) The management of retrograde ejaculation: a systematic review and update. Fertil Steril 97:306–312. https://doi.org/10.1016/j.fertnstert.2011.11.019
Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB (2000) Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 163:460–463
Joice GA, Liu JL, Burnett AL (2021) Medical treatment of recurrent ischaemic priapism: a review of current molecular therapeutics and a new clinical management paradigm. BJU Int 127:498–506. https://doi.org/10.1111/bju.15370
Jordan GH (2008) The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: a prospective, single-center, non-placebo-controlled study. J Sex Med 8:180–187. https://doi.org/10.1111/j.1743-6109.2007.00651.x
Jung J, Choi S, Cho SH, Ghim JL, Hwang A, Kim U, Kim BS, Koguchi A, Miyoshi S, Okabe H, Bae KS, Lim HS (2010) Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers. Clin Ther 32(6):1178–1187. https://doi.org/10.1016/j.clinthera.2010.06.011
Kadioglu A, Tefekli A, Köksal T, Usta M, Erol H (2000) Treatment of Peyronie’s disease with oral colchicine: long-term results and predictive parameters of successful outcome. Int J Impot Res 12:169–175. https://doi.org/10.1038/sj.ijir.3900519
Kamenov ZA (2015) A comprehensive review of erectile dysfunction in men with diabetes. Exp Clin Endocrinol Diabetes 123:141–158. https://doi.org/10.1055/s-0034-1394383
Kamischke A, Nieschlag E (2002) Update on medical treatment of ejaculatory disorders. Int J Androl 25:333–344. https://doi.org/10.1046/j.1365-2605.2002.00379.x
Khan S, Amjad A, Rowland D (2019) Potential for long-term benefit of cognitive behavioral therapy as an adjunct treatment for men with erectile dysfunction. J Sex Med 16:300–306. https://doi.org/10.1016/j.jsxm.2018.12.014
Khera M, Bella A, Karpman E, Brant W, Christine B, Kansas B, Jones L, Kohler T, Bennett N, Rhee E, Henry G (2018) Penile prosthesis implantation in patients with Peyronie’s disease: results of the PROPPER study demonstrates a decrease in patient-reported depression. J Sex Med 15:786–788. https://doi.org/10.1016/j.jsxm.2018.02.024
Kim SC, Lee YS, Seo KK, Jung GW, Kim TH (2014) Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients. Int J Impot Res 26:87–93. https://doi.org/10.1038/ijir.2013.41
Kirkham A (2012) MRI of the penis. Br J Radiol 85 Spec No 1:S86–S93. https://doi.org/10.1259/bjr/63301362
Kliesch S (2020) Über den Zusammenhang von allgemeiner und sexueller Gesundheit. Dtsch Ärztebl Int 117:643–644
Kloner RA, Goldstein I, Kirby MG, Parker JD, Sadovsky R (2018) Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly 2 decades on the market. Sex Med Rev 6:583–594. https://doi.org/10.1016/j.sxmr.2018.03.008
Klotz T, Bauer RJ, Rohde G (2002) Effect of renal impairment on the single-dose pharmacokinetics of vardenafil 20 mg, a selective PDE-5 inhibitor, for the treatment of erectile dysfunction. Pharmacotherapy 22:418
Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R (2005) Sexual dysfunction and cardiac risk (the second Princeton consensus conference). Am J Cardiol 96:313–321. https://doi.org/10.1016/j.amjcard.2005.03.065
Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF (2017) Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur Urol 71:223–233. https://doi.org/10.1016/j.eururo.2016.05.050
Mahon J, Dornbier R, Wegrzyn G, Faraday MM, Sadeghi-Nejad H, Hakim L, McVary KT (2020) Infectious adverse events following the placement of a penile prosthesis: a systematic review. Sex Med Rev 8:348–354. https://doi.org/10.1016/j.sxmr.2019.07.005
Maiorino MI, Bellastella G, Esposito K (2015) Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl 17:5–10. https://doi.org/10.4103/1008-682X.137687
Maiorino MI, Bellastella G, Giugliano D, Esposito K (2018) From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Investig 41:1249–1258. https://doi.org/10.1007/s40618-018-0872-6
Margolin EJ, Pagano MJ, Aisen CM, Onyeji IC, Stahl PJ (2018) Beyond curvature: prevalence and characteristics of penile volume-loss deformities in men with Peyronie’s disease. Sex Med 8:309–315. https://doi.org/10.1016/j.esxm.2018.07.003
Masters WH, Johnson VE (1970) Human sexual inadequacy. Little, Brown, Boston
McCabe MP, Althof SE (2014) A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man’s inability to have sex? J Sex Med 11:347–363. https://doi.org/10.1111/jsm.12374
Melnik T, Soares BG, Nasselo AG (2007) Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev 18:CD004825. https://doi.org/10.1002/14651858.CD004825.pub2
Mishra K, Loeb A, Bukavina L, Baumgarten A, Beilan J, Mendez M, DiGiorgio L, Fu L, Carrion R (2020) Management of priapism: a contemporary review. Sex Med Rev 8:131–139. https://doi.org/10.1016/j.sxmr.2019.01.001
Montejo AL, Montejo L, Navarro-Cremades F (2015) Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry 28:418–423. https://doi.org/10.1097/YCO.0000000000000198
Montejo AL, Prieto N, de Alarcón R, Casado-Espada N, de la Iglesia J, Montejo L (2019) Management strategies for antidepressant-related sexual dysfunction: a clinical approach. J Clin Med 80:1640. https://doi.org/10.3390/jcm8101640
Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C (2008) Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54:924–931. https://doi.org/10.1016/j.eururo.2008.06.083
Montorsi F, Brock G, Stolzenburg JU, et al (2014) Effects of tadalafil treatment on erectile function recovery following bilateral nervesparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol 65(3):587–596. Epub 2013/10/31
Mulhall JP (2003) Expanding the paradigm for plaque development in Peyronie’s disease. Int J Impot Res 15(Suppl 5):S93–S102. https://doi.org/10.1038/sj.ijir.3901082
Mulhall JP, Simmons J (2007) Assessment of comparative treatment satisfaction with sildenafil citrate and penile injection therapy in patients responding to both. BJU Int 100:1313–1316. https://doi.org/10.1111/j.1464-410X.2007.07266.x
Mulhall JP, Schiff J, Guhring P (2006) An analysis of the natural history of Peyronie’s disease. J Urol 175:2115–2118.; ; discussion 2118. https://doi.org/10.1016/S0022-5347(06)00270-9
Musicki B, Champion HC, Becker RE, Kramer MF, Liu T, Sezen SF, Burnett AL (2005) In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect. J Urol 174(4 Pt 1):1493–1496. https://doi.org/10.1097/01.ju.0000173006.47623.2c
Musicki B, Bella AJ, Bivalacqua TJ, Davies KP, DiSanto ME, Gonzalez-Cadavid NF, Hannan JL, Kim NN, Podlasek CA, Wingard CJ, Burnett AL (2015) Basic science evidence for the link between erectile dysfunction and cardiometabolic dysfunction. J Sex Med 12:2233–2255. https://doi.org/10.1111/jsm.13069
Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC (2012) The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 87:766–778. https://doi.org/10.1016/j.mayocp.2012.06.015
Nguyen HMT, Gabrielson AT, Hellstrom WJG (2017) Erectile dysfunction in young men—a review of the prevalence and risk factors. Sex Med Rev 5:508–520. https://doi.org/10.1016/j.sxmr.2017.05.004
Nicolai MP, Liem SS, Both S, Pelger RC, Putter H, Schalij MJ, Elzevier HW (2014) A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J 22:11–19. https://doi.org/10.1007/s12471-013-0482-z
NIH Consensus Conference (1993) Impotence. NIH Consensus Development Panel on Impotence. JAMA 270:83–90
Olujohungbe AB, Adeyoju A, Yardumian A, Akinyanju O, Morris J, Westerdale N, Akenova Y, Kehinde MO, Anie K, Howard J, Brooks A, Davis VA, Khoriatry AI (2011) A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial—the priapism in sickle cell study. J Androl 32:375–382. https://doi.org/10.2164/jandrol.110.010934
Osmonov D, Christopher AN, Blecher GA, Falcone M, Soave A, Dahlem R, Czeloth K, Bannowsky A, Matanes E, Ward S, Martínez-Salamanca JI, Bettocchi C, Garaffa G, Reisman Y, Corona G (2020) Clinical recommendations from the European Society for Sexual Medicine exploring partner expectations, satisfaction in male and phalloplasty cohorts, the impact of penile length, girth and implant type, reservoir placement, and the influence of comorbidities and social circumstances. J Sex Med 17:210–237. https://doi.org/10.1016/j.jsxm.2019.10.016
Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V (2009) A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol 56:363–369. https://doi.org/10.1016/j.eururo.2009.05.012
Palmisano F, Boeri L, Cristini C, Antonini G, Spinelli MG, Franco G, Longo F, Gadda F, Colombo F, Montanari E (2018) Comparison of infrapubic vs. penoscrotal approaches for 3-piece inflatable penile prosthesis placement: do we have a winner? Sex Med Rev 6:631–639. https://doi.org/10.1016/j.sxmr.2018.03.007
Park NC, Kim TN, Park HJ (2013) Treatment strategy for non-responders to PDE5 inhibitors. World J Mens Health 31:31–35. https://doi.org/10.5534/wjmh.2013.31.1.31
Patterson B, Bedding A, Hayley J, Payne C, Mitschell M (2002) Dosenormalised pharmacokinetics of tadalafil adeministered as a single dose to healthy volunteers. Eur Urol 152(Supp 1): Abstr. 600
Paulis G, Barletta D, Turchi P, Vitarelli A, Dachille G, Fabiani A, Gennaro R (2015) Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study. Res Rep Urol 8:1–10. https://doi.org/10.2147/RRU.S97194
Pelit ES, Dokumacı DŞ, Kati B, Yağmur İ, Arslan E, Tunçtekin A, Kırteke A, Çiftçi H, Yeni E (2019) Carotid artery intima-media thickness can predict the response of patients with erectile dysfunction to phosphodiesterase 5 inhibitors. Int J Impot Res 31:139–144. https://doi.org/10.1038/s41443-018-0103-x
Philippou YA, Jung JH, Steggall MJ, O’Driscoll ST, Bakker CJ, Bodie JA, Dahm P (2018) Penile rehabilitation for postprostatectomy erectile dysfunction. Cochrane Database Syst Rev 23:CD012414. https://doi.org/10.1002/14651858.CD012414.pub2
Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, Mancia G (2004) Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens 17(12 Pt 1):1135–1142. https://doi.org/10.1016/j.amjhyper.2004.07.004
Porst H (2021) Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), peyronie’s disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 9(1):93–122. https://doi.org/10.1016/j.sxmr.2020.01.006
Pryor JP, Ralph DJ (2002) Clinical presentations of Peyronie’s disease. Int J Impot Res 14(5):414–417. https://doi.org/10.1038/sj.ijir.3900877. PMID: 12454695
Pyke RE (2020) Sexual performance anxiety. Sex Med Rev 8:183–190. https://doi.org/10.1016/j.sxmr.2019.07.001
Qin F, Gao L, Qian S, Fu F, Yang Y, Yuan J (2018a) Advantages and limitations of sleep-related erection and rigidity monitoring: a review. Int J Impot Res 30:192–201. https://doi.org/10.1038/s41443-018-0032-8
Qin F, Wang S, Li J, Wu C, Yuan J (2018b) The early use of vacuum therapy for penile rehabilitation after radical prostatectomy: systematic review and meta-analysis. Am J Mens Health 12:2136–2143. https://doi.org/10.1177/1557988318797409
Radmayr C, Bogaert G, Dogan H, Nijman J, Silay M, Stein R, Tekgül S (2020) EAU guideline paediatric urology. European Urology. https://uroweb.org/guideline/paediatric-urology/
Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L (2010) The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med 7:2359–2374. https://doi.org/10.1111/j.1743-6109.2010.01850.x
Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN (2014) Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf 4(37):19–31. https://doi.org/10.1007/s40264-013-0129-4
Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G (2010) A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie’s disease. J Sex Med 7(4 Pt 1):1529–1537. https://doi.org/10.1111/j.1743-6109.2009.01584.X. Erratum in: J Sex Med. 2010 Jun;7(6):2296
Rizk PJ, Krieger JR, Kohn TP, Pastuszak AW (2018) Low-intensity shockwave therapy for erectile dysfunction. Sex Med Rev 6:624–630. https://doi.org/10.1016/j.sxmr.2018.01.002
Robert Koch Institut (2014). https://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsB/maennerbericht/maennerbericht_tab.html
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44:637–649. https://doi.org/10.1016/j.eururo.2003.08.015
Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M (2004) The multinational Men’s attitudes to life events and sexuality (MALES) study. I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 20:607–617. https://doi.org/10.1185/030079904125003467
Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, McNicholas TA (2001) Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 88:68–71. https://doi.org/10.1046/j.1464-410x.2001.02260.x
Salonia A, Bettocchi C, Carvalho J, Corona G, Jones TH, Kadioglu A, Martinez-Salamanca JI, Minhas S, Serefoglu EC, Verze P (2020) EAU guidelines on sexual and reproductive health. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Sexual-and-Reproductive-Health-2020.pdf
Sari Motlagh R, Abufaraj M, Yang L, Mori K, Pradere B, Laukhtina E, Mostafaei H, Schuettfort VM, Quhal F, Montorsi F, Amjadi M, Gratzke C, Shariat SF (2021) Penile rehabilitation strategy after nerve-sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials. J Urol 205:1018–1030. https://doi.org/10.1097/JU.0000000000001584
Scherzer ND, Dick B, Gabrielson AT, Alzweri LM, Hellstrom WJG (2019) Penile prosthesis complications: planning, prevention, and decision making. Sex Med Rev 7:349–359. https://doi.org/10.1016/j.sxmr.2018.04.002
Schmidt HM, Munder T, Gerger H, Frühauf S, Barth J (2014) Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: a narrative review and meta-analysis. J Sex Med 11:1376–1391. https://doi.org/10.1111/jsm.12520
Scott FB, Bradley WE, Timm GW (1973) Management of erectile impotence. Use of implantable inflatable prosthesis. Urology 2:80–82. https://doi.org/10.1016/0090-4295(73)90224-0
Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, Becher EF, Dean J, Giuliano F, Hellstrom WJ, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO (2014) An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med 2:41–59. https://doi.org/10.1002/sm2.27
Shimon I, Hirsch D, Tsvetov G, Robenshtok E, Akirov A, Fraenkel M, Eizenberg Y, Herzberg D, Barzilay-Yoseph L, Livner A, Friedrich I, Manisterski Y, Ishay A, Yoel U, Masri H (2019) Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years. Endocrine 65:656–661. https://doi.org/10.1007/s12020-019-01962-5
Sikka SC, Hellstrom WJ, Brock G, Morales AM (2013) Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med 10:120–129. https://doi.org/10.1111/j.1743-6109.2012.02825.x
Sinha V, Elliott S, Ibrahim E, Lynne CM, Brackett NL (2017) Reproductive health of men with spinal cord injury. Top Spinal Cord Inj Rehabil 23:31–41. https://doi.org/10.1310/sci2301-31
Small MP, Carrion HM, Gordon JA (1975) Small-Carrion penile prosthesis. New implant for management of impotence. Urology 5:479–486. https://doi.org/10.1016/0090-4295(75)90071-0
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS (2016) Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med 374:611–624. https://doi.org/10.1056/NEJMoa1506119
Soave A, König F, Dahlem R, Rink M, Riechardt S, Fisch M, Briken P, Nieder (2021) ‚Induratio penis plastica: Herausforderungen der somatischen Therapie und Unterstützungsmöglichkeiten durch Psychotherapie‘. Z SEXUALFORSCH 34(4):208–218. https://doi.org/10.1055/a-1674-2041
Soave A, Laurich S, Dahlem R, Vetterlein MW, Engel O, Nieder T, Briken P, Rink M, Fisch M, Reiss P (2019) Negative self-perception and self-attitude of sexuality is a risk factor for patient dissatisfaction following penile surgery with small intestinal submucosa grafting for the treatment of severe Peyronie’s disease. J Clin Med 28:81121. https://doi.org/10.3390/jcm8081121
Sokolakis I, Hatzichristodoulou G (2019) Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials. Int J Impot Res 31:177–194. https://doi.org/10.1038/s41443-019-0117-z
Sokolakis I, Hatzichristodoulou G (2020) Current trends in the surgical treatment of congenital penile curvature. Int J Impot Res 32:64–74. https://doi.org/10.1038/s41443-019-0177-0
Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA (1999) Tamoxifen versus placebo in the treatment of Peyronie’s disease. J Urol 162:2003–2005. https://doi.org/10.1016/s0022-5347(05)68087-1
Towe M, Huynh LM, El-Khatib F, Gonzalez J, Jenkins LC, Yafi FA (2019) A review of male and female sexual function following colorectal surgery. Sex Med Rev 7:422–429. https://doi.org/10.1016/j.sxmr.2019.04.001
Traish A, Kim N (2005) The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2:759–770. https://doi.org/10.1111/j.1743-6109.2005.00094.x
Trost LW, Munarriz R, Wang R, Morey A, Levine L (2016) External mechanical devices and vascular surgery for erectile dysfunction. J Sex Med 13:1579–1617. https://doi.org/10.1016/j.jsxm.2016.09.008
Valiquette L, Montorsi F, Auerbach S (2008) Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction—RELY-II. Can Urol Assoc J 2:187–195. https://doi.org/10.5489/cuaj.590. Erratum in: can Urol Assoc J (2009) 3:376
Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI (2013) Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes 6:99–109. https://doi.org/10.1161/CIRCOUTCOMES.112.966903
Vreugdenhil S, Freire Jorge PJ, van Driel MF, Nijsten MW (2019) Ischemic priapism as a model of exhausted metabolism. Physiol Rep 7:e13999. https://doi.org/10.14814/phy2.13999
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M (2005) A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2:492–497. https://doi.org/10.1111/j.1743-6109.2005.00070.x
Wang TD, Lee WJ, Yang SC, Lin PC, Tai HC, Liu SP, Huang CH, Chen WJ, Chen MF, Hsieh JT (2016) Clinical and imaging outcomes up to 1 year following balloon angioplasty for isolated penile artery stenoses in patients with erectile dysfunction: the PERFECT-2 study. J Endovasc Ther 23:867–877. https://doi.org/10.1177/1526602816669337
Weidner W, Hauck EW, Schnitker J, Peyronie’s Disease Study Group of Andrological Group of German Urologists (2005) Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease: a prospective, placebo-controlled, randomized study. Eur Urol 47:530–535.; discussion 535-6. https://doi.org/10.1016/j.eururo.2004.12.022
Xu ZH, Pan D, Liu TY, Yuan MZ, Zhang JY, Jiang S, Wang XS, Guan Y, Zhao ST (2019) Effect of prolactin on penile erection: a cross-sectional study. Asian J Androl 21:587–591. https://doi.org/10.4103/aja.aja_22_19
Yafi FA, Pinsky MR, Sangkum P, Hellstrom WJ (2015) Therapeutic advances in the treatment of Peyronie’s disease. Andrology 3:650–660. https://doi.org/10.1111/andr.12058
Yafi FA, Anaissie J, Zurawin J, Sikka SC, Hellstrom WJ (2016) Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease. J Sex Med 13:684–689. https://doi.org/10.1016/j.jsxm.2016.02.105
Young Academic Urologists Men’s Health Group (2017) Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? Nat Rev Urol 14:593–606. https://doi.org/10.1038/nrurol.2017.119
Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W (2019) Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. J Sex Med 16:1005–1017. https://doi.org/10.1016/j.jsxm.2019.04.004
Zou Z, Lin H, Zhang Y, Wang R (2019) The role of nocturnal penile tumescence and rigidity (NPTR) monitoring in the diagnosis of psychogenic erectile dysfunction: a review. Sex Med Rev 7:442–454. https://doi.org/10.1016/j.sxmr.2018.10.005
Zumbé J, Porst H, Sommer F, Grohmann W, Beneke M, Ulbrich E (2008) Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study. Eur Urol 54:204–210. https://doi.org/10.1016/j.eururo.2008.03.056
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Soave, A., Kliesch, S. (2023). Disorders of Erection, Cohabitation, and Ejaculation. In: Nieschlag, E., Behre, H.M., Kliesch, S., Nieschlag, S. (eds) Andrology. Springer, Cham. https://doi.org/10.1007/978-3-031-31574-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-031-31574-9_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31573-2
Online ISBN: 978-3-031-31574-9
eBook Packages: MedicineMedicine (R0)